{"id":447,"date":"2023-06-08T09:25:23","date_gmt":"2023-06-08T09:25:23","guid":{"rendered":"https:\/\/ntangels.com\/?page_id=447"},"modified":"2023-06-08T09:25:24","modified_gmt":"2023-06-08T09:25:24","slug":"investmen","status":"publish","type":"page","link":"https:\/\/ntangels.com\/en\/investmen","title":{"rendered":"INVESTMENT"},"content":{"rendered":"\n<p>Owns Newsight Tech Angels LLC as a U.S. subsidiary<\/p>\n\n\n\n<p>Within the Angel Investment Fund, investment recovery will be made through the following. <\/p>\n\n\n\n<ul class=\"wp-block-list\"><li> Approx. 60%: Investments in Japanese drug discovery seeds and platform technologies<\/li><li>Approx. 20%: Investments in non-Japanese drug discovery seeds and platform technologies<\/li><li>20%: Portfolio investment in U.S. angel funds<\/li><li>As a result of hands-on support:<\/li><li>Licensing to Asian countries including Japan<\/li><li>Partnerships with pharmaceutical companies<\/li><li>Venture capital funding<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Owns Newsight Tech Angels LLC as a U.S. subsidiary Within the Angel Investment Fund, investment recovery will be made through the following. Approx. 60%: Investments in Japanese drug discovery seeds and platform technologies Approx. 20%: Investments in non-Japanese drug discovery seeds and platform technologies 20%: Portfolio investment in U.S. angel funds As a result of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/ntangels.com\/en\/investmen\" class=\"more-link\">Read more<span class=\"screen-reader-text\"> &#8220;INVESTMENT&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_locale":"en_US","_original_post":"http:\/\/www.ntangels.com\/?page_id=23","vkexunit_cta_each_option":"","footnotes":""},"class_list":["post-447","page","type-page","status-publish","hentry","en-US"],"aioseo_notices":[],"featured_media_urls":[],"_links":{"self":[{"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/pages\/447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/comments?post=447"}],"version-history":[{"count":1,"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/pages\/447\/revisions"}],"predecessor-version":[{"id":448,"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/pages\/447\/revisions\/448"}],"wp:attachment":[{"href":"https:\/\/ntangels.com\/wp-json\/wp\/v2\/media?parent=447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}